Similar articles for PMID: 24777811

Year	Number of Results
2001	1
2002	1
2003	3
2004	5
2005	11
2006	6
2007	6
2008	11
2009	7
2010	10
2011	10
2012	6
2013	15
2014	12
2015	10
2016	14
2017	7
2018	5
2019	4
2020	3
2021	3
2022	3
2024	0

1

Effects of ezetimibe on endothelial progenitor cells and microparticles in high-risk patients.

Lins LC, França CN, Fonseca FA, Barbosa SP, Matos LN, Aguirre AC, Bianco HT, do Amaral JB, Izar MC. Lins LC, et al. Cell Biochem Biophys. 2014 Sep;70(1):687-96. doi: 10.1007/s12013-014-9973-9. Cell Biochem Biophys. 2014. PMID: 24777811 Clinical Trial.

2

Effects of ezetimibe on markers of synthesis and absorption of cholesterol in high-risk patients with elevated C-reactive protein.

Barbosa SP, Lins LC, Fonseca FA, Matos LN, Aguirre AC, Bianco HT, Amaral JB, França CN, Santana JM, Izar MC. Barbosa SP, et al. Life Sci. 2013 May 2;92(14-16):845-51. doi: 10.1016/j.lfs.2013.02.018. Epub 2013 Mar 16. Life Sci. 2013. PMID: 23507424 Free article. Clinical Trial.

3

Effects of simvastatin/ezetimibe on microparticles, endothelial progenitor cells and platelet aggregation in subjects with coronary heart disease under antiplatelet therapy.

Camargo LM, França CN, Izar MC, Bianco HT, Lins LS, Barbosa SP, Pinheiro LF, Fonseca FA. Camargo LM, et al. Braz J Med Biol Res. 2014 May;47(5):432-7. doi: 10.1590/1414-431x20143628. Epub 2014 May 2. Braz J Med Biol Res. 2014. PMID: 24760119 Free PMC article. Clinical Trial.

4

Achievement of specified low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol apolipoprotein B, and high-sensitivity C-reactive protein levels with ezetimibe/simvastatin or atorvastatin in metabolic syndrome patients with and without atherosclerotic vascular disease (from the VYMET study).

Robinson JG, Ballantyne CM, Hsueh W, Rosen J, Lin J, Shah A, Lowe RS, Hanson ME, Tershakovec AM. Robinson JG, et al. J Clin Lipidol. 2011 Nov-Dec;5(6):474-82. doi: 10.1016/j.jacl.2011.06.004. Epub 2011 Jun 15. J Clin Lipidol. 2011. PMID: 22108151 Clinical Trial.

5

Comparison of effects of ezetimibe/simvastatin versus simvastatin versus atorvastatin in reducing C-reactive protein and low-density lipoprotein cholesterol levels.

Pearson T, Ballantyne C, Sisk C, Shah A, Veltri E, Maccubbin D. Pearson T, et al. Am J Cardiol. 2007 Jun 15;99(12):1706-1713. doi: 10.1016/j.amjcard.2007.01.062. Epub 2007 May 2. Am J Cardiol. 2007. PMID: 17560879

6

Achieving lipoprotein goals in patients at high risk with severe hypercholesterolemia: efficacy and safety of ezetimibe co-administered with atorvastatin.

Stein E, Stender S, Mata P, Sager P, Ponsonnet D, Melani L, Lipka L, Suresh R, Maccubbin D, Veltri E; Ezetimibe Study Group. Stein E, et al. Am Heart J. 2004 Sep;148(3):447-55. doi: 10.1016/j.ahj.2004.03.052. Am Heart J. 2004. PMID: 15389231 Clinical Trial.

7

Age, abdominal obesity, and baseline high-sensitivity C-reactive protein are associated with low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B responses to ezetimibe/simvastatin and atorvastatin in patients with metabolic syndrome.

Robinson JG, Ballantyne CM, Hsueh WA, Rosen JB, Lin J, Shah AK, Tomassini JE, Lowe RS, Tershakovec AM. Robinson JG, et al. J Clin Lipidol. 2013 Jul-Aug;7(4):292-303. doi: 10.1016/j.jacl.2013.03.007. Epub 2013 Apr 3. J Clin Lipidol. 2013. PMID: 23890516 Clinical Trial.

8

High-dose atorvastatin reloading before percutaneous coronary intervention increased circulating endothelial progenitor cells and reduced inflammatory cytokine expression during the perioperative period.

Ye H, He F, Fei X, Lou Y, Wang S, Yang R, Hu Y, Chen X. Ye H, et al. J Cardiovasc Pharmacol Ther. 2014 May;19(3):290-5. doi: 10.1177/1074248413513500. Epub 2013 Dec 16. J Cardiovasc Pharmacol Ther. 2014. PMID: 24346155 Clinical Trial.

9

Effect of ezetimibe/atorvastatin combination on oxidized low density lipoprotein cholesterol in patients with coronary artery disease or coronary artery disease equivalent.

Azar RR, Badaoui G, Sarkis A, Azar M, Aydanian H, Harb S, Achkouty G, Kassab R. Azar RR, et al. Am J Cardiol. 2010 Jul 15;106(2):193-7. doi: 10.1016/j.amjcard.2010.03.016. Am J Cardiol. 2010. PMID: 20599002 Clinical Trial.

10

Ezetimibe/simvastatin vs atorvastatin in patients with type 2 diabetes mellitus and hypercholesterolemia: the VYTAL study.

Goldberg RB, Guyton JR, Mazzone T, Weinstock RS, Polis A, Edwards P, Tomassini JE, Tershakovec AM. Goldberg RB, et al. Mayo Clin Proc. 2006 Dec;81(12):1579-88. doi: 10.4065/81.12.1579. Mayo Clin Proc. 2006. PMID: 17165637 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

129 results

Results by year